Rocket Lab's Iridium Equation: When a Share Price Becomes Its Own Headwind

Rocket Lab shares fell 19.4% over seven sessions, erasing $10B in market cap, driven by SpaceX's FCC complaint and deal structure, not fundamentals.

There is a particular kind of market anxiety that has little to do with whether a company can execute on its promises. Rocket Lab is currently living inside that anxiety. The launch specialist has spent seven consecutive trading sessions in decline, shedding 19.4 percent of its share value — a slide that has erased roughly $10 billion in market capitalization, according to media reports — while the S&P 500 drifted just 0.9 percent lower over the same stretch. Friday added another 4.1 percent to the damage, bringing the weekly loss to 11 percent.

The instinct is to read this as a verdict on the business. That instinct would be wrong.

A Complaint That Became a Lever

The trigger for the sell-off was not a missed earnings target or a delayed rocket program. It was a filing. SpaceX has lodged a complaint with the Federal Communications Commission regarding Iridium, the satellite operator Rocket Lab has agreed to acquire. Matthew Turk, a satellite policy staffer at SpaceX, accused Iridium of a "well-documented history of anti-competitive attacks against competitors and American consumers," and raised concerns about potential spectrum interference from future Starlink gateways.

Notably, SpaceX has not opposed the acquisition itself — it has asked for closer scrutiny during the license transfer process. That distinction mattered little to traders. The stock dropped 6 percent on the news.

The outsized reaction traces back to the deal's architecture. Rocket Lab's roughly $8 billion acquisition of Iridium offers shareholders $27 in cash per share plus a variable number of Rocket Lab shares, calculated against the company's ten-day volume-weighted average price shortly before closing. The math creates a feedback loop: when Rocket Lab's stock falls, the exchange ratio shifts, making the transaction less attractive to Iridium shareholders — which in turn fuels more uncertainty about whether the deal closes, which pressures the stock further.

Market observers note that relatively few investors have fully absorbed how this mechanism works. The result is that regulatory noise gets converted, almost mechanically, into share-price pressure. The news itself was not the problem; the structure that amplified it was.

The Calendar Ahead

Rocket Lab reaffirmed its timeline for the transaction on August 10. The waiting period under US antitrust law expired on August 12, registration documents have been filed with the SEC, and FCC applications for the transfer of Iridium's licenses have been in motion since August 10. Iridium shareholders are scheduled to vote on the combination on September 24.

Until that vote, any piece of deal-relevant news becomes a potential lever on the exchange ratio. That helps explain why the stock now sits roughly 18 percent below its 50-day moving average and 58 percent beneath its 52-week high from May. The technical picture reinforces the nervousness: the relative strength index reads 34.8, signaling oversold conditions, while annualized volatility of 73 percent and a 20 percent gap below the 200-day average paint a portrait of a stock in churn.

The Fundamentals Tell Another Story

Strip away the deal mechanics, and the operating narrative is hard to fault. Rocket Lab posted record second-quarter revenue of $234 million, up 62 percent year over year and $34 million above the prior quarter. The backlog climbed to a record $2.36 billion, a 137 percent jump. Management guided third-quarter revenue to between $250 million and $265 million, with GAAP gross margins of 29 to 31 percent.

The operational cadence has been relentless. The 93rd Electron mission launched successfully on August 20. The US Space Force brought Rocket Lab into its Space Data Network Consortium with a $12 million award and tied the company to the $981 million NITE-STAR program. A $397 million contract for the SB-AMTI program followed, alongside more than $437 million in new launch agreements covering Electron, HASTE, and Neutron, plus over $160 million for the construction of three geostationary satellites. Kepler Communications signed on as the first paying customer for a dedicated Neutron mission, and Viasat selected Rocket Lab to build a jamming-resistant satellite for security applications. Neutron, the company's next-generation rocket, remains on track for delivery to the launch pad in the fourth quarter of 2026.

Some insider selling has occurred during this stretch — executives including chief operating officer Frank Klein disposed of shares under pre-arranged trading plans to cover tax obligations tied to equity compensation. In each case, the managers retained the majority of their holdings afterward.

A Structural Lesson in Modern Deal-Making

The broader takeaway extends beyond Rocket Lab. As billion-dollar acquisitions increasingly incorporate variable stock components, a company's own share price becomes a playing field for competitors and regulators alike. When SpaceX files a complaint, it influences — through the indirect route of deal mechanics — the price Rocket Lab ultimately pays for Iridium. That is not a sign of operational weakness. It is a structural feature of contemporary merger financing that investors are still learning to price in.

The stock closed at 55.60 euros, roughly 71 percent above its 52-week low from November but a long way from the highs of May. The shareholder vote on September 24 will not resolve the regulatory questions, but it will mark a moment of clarity. Until then, the feedback loop remains in force — and the gap between what the company is achieving and what its share price is expressing may be the most instructive number of all.